Jennifer Cochran
Director/Board Member bij OMNIAB, INC.
Vermogen: 609 948 $ op 31-03-2024
Profiel
Dr. Jennifer Cochran is a Board Advisor at Switch Bioworks, Inc., a Co-Founder at Red Tree Venture Capital, a Professor at Stanford University and an Independent Director at OmniAb Operations, Inc. She is on the Board of Directors at OmniAb, Inc., Biograph 55, Inc., Revel Pharmaceuticals, Inc., Rondo Therapeutics, Inc., Virsti Therapeutics, Inc. and OmniAb Operations, Inc. Dr. Cochran was previously employed as an Independent Director by Ligand Pharmaceuticals, Inc. and a Chief Scientist by Lagunita Biosciences LLC.
She also served on the board at Combangio, Inc., Nodus Therapeutics, Inc. and xCella Biosciences, Inc. She received her undergraduate degree from the University of Delaware and a doctorate degree from Massachusetts Institute of Technology.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
OMNIAB, INC.
0.08% | 12-07-2023 | 96 878 ( 0.08% ) | 525 079 $ | 31-03-2024 |
| 01-11-2022 | 1 161 ( 0.01% ) | 84 869 $ | 31-03-2024 |
Actieve functies van Jennifer Cochran
| Bedrijven | Functie | Begin |
|---|---|---|
| OMNIAB, INC. | Director/Board Member | 01-11-2022 |
Revel Pharmaceuticals, Inc.
 Revel Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Revel Pharmaceuticals, Inc. engages in the provision of therapeutic designer enzymes to degrade molecular damage that accumulates with aging. The company was founded by Aaron Cravens, David Spiegel and Jason Crawford in 2019 and is headquartered in San Francisco, CA. | Director/Board Member | - |
| Virsti Therapeutics, Inc. | Director/Board Member | - |
Red Tree Venture Capital
 Red Tree Venture Capital Investment ManagersFinance Red Tree Venture Capital is a venture capital firm founded by Heath Lukatch. The firm is headquartered in portola, California. | Founder | 01-01-2020 |
Switch Bioworks, Inc.
 Switch Bioworks, Inc. Chemicals: AgriculturalProcess Industries Switch Bioworks, Inc. is a biofertilizer company based in San Carlos, CA. The company's mission is to feed the world sustainably by engineering naturally occurring microbes to become sustainable fertilizer producing factories directly on the roots of plants. The company produces microbes and formulate them into a powder, which farmers rehydrate to awaken and apply at crop sowing. The microbes first proliferate alongside germinating plants, and then switch on nitrogen fertilizer production through a proprietary mechanism. This process is more efficient, lower cost, and has no toxic gas emissions or runoff. The company was founded by Elizabeth Sattely, Tim Schnabel, Jim Swartz, Jennifer Cochran, and Amy L. Chang, with Tim Schnabel as the CEO since incorporation. | Founder | 01-03-2022 |
OmniAb Operations, Inc.
 OmniAb Operations, Inc. BiotechnologyHealth Technology OmniAb Operations, Inc. operates as a drug discovery company. It provides pharmaceutical industry partners access to antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform includes the Biological Intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse, that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company is headquartered in Emeryville, CA. | Director/Board Member | - |
| Stanford University | Corporate Officer/Principal | 01-01-2005 |
Biograph 55, Inc.
 Biograph 55, Inc. BiotechnologyHealth Technology Biograph 55, Inc. is a biotechnology firm. The CEO of the American company is Paul C Tumeh. | Director/Board Member | - |
Rondo Therapeutics, Inc.
 Rondo Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Rondo Therapeutics, Inc. develops bispecific therapeutic antibodies to fight cancer. The American company was founded by Nathan D. Trinklein, Shelley Force Aldred. Shelley Force Aldred has been the CEO since incorporation. | Director/Board Member | - |
Eerdere bekende functies van Jennifer Cochran
| Bedrijven | Functie | Einde |
|---|---|---|
| ░░░░░░░░ ░░░░░░░░░░░ ░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░ | - |
| ░░░░░░ ░░░░░░░░░░░░░░░ ░░░░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Opleiding van Jennifer Cochran
| Massachusetts Institute of Technology | Doctorate Degree |
| University of Delaware | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| LIGAND PHARMACEUTICALS INCORPORATED | Health Technology |
| OMNIAB, INC. | Commercial Services |
| Bedrijven in privébezit | 11 |
|---|---|
Lagunita Biosciences LLC
 Lagunita Biosciences LLC Investment ManagersFinance Lagunita Biosciences LLC (Lagunita Biosciences) is a venture Capital firm founded in 2015 by Mark S. Blumenkranz. The firm is headquartered in Menlo Park, California. | Finance |
xCella Biosciences, Inc.
 xCella Biosciences, Inc. Pharmaceuticals: MajorHealth Technology xCella Biosciences, Inc. engages in the development of protein therapeutics for cancer treatment. Its pipeline is XC-201, a tumor targeting agent. The company was founded by Bob Chen and K. Dane Wittrup and is headquartered in Menlo Park, CA. | Health Technology |
Revel Pharmaceuticals, Inc.
Revel Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Revel Pharmaceuticals, Inc. engages in the provision of therapeutic designer enzymes to degrade molecular damage that accumulates with aging. The company was founded by Aaron Cravens, David Spiegel and Jason Crawford in 2019 and is headquartered in San Francisco, CA. | Health Technology |
Red Tree Venture Capital
Red Tree Venture Capital Investment ManagersFinance Red Tree Venture Capital is a venture capital firm founded by Heath Lukatch. The firm is headquartered in portola, California. | Finance |
Combangio, Inc.
 Combangio, Inc. Miscellaneous Commercial ServicesCommercial Services Combangio, Inc. operates as an investment holding company. The company was headquartered in Menlo Park, CA. | Commercial Services |
Biograph 55, Inc.
Biograph 55, Inc. BiotechnologyHealth Technology Biograph 55, Inc. is a biotechnology firm. The CEO of the American company is Paul C Tumeh. | Health Technology |
| Virsti Therapeutics, Inc. | |
OmniAb Operations, Inc.
OmniAb Operations, Inc. BiotechnologyHealth Technology OmniAb Operations, Inc. operates as a drug discovery company. It provides pharmaceutical industry partners access to antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform includes the Biological Intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse, that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company is headquartered in Emeryville, CA. | Health Technology |
Rondo Therapeutics, Inc.
Rondo Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Rondo Therapeutics, Inc. develops bispecific therapeutic antibodies to fight cancer. The American company was founded by Nathan D. Trinklein, Shelley Force Aldred. Shelley Force Aldred has been the CEO since incorporation. | Commercial Services |
Switch Bioworks, Inc.
Switch Bioworks, Inc. Chemicals: AgriculturalProcess Industries Switch Bioworks, Inc. is a biofertilizer company based in San Carlos, CA. The company's mission is to feed the world sustainably by engineering naturally occurring microbes to become sustainable fertilizer producing factories directly on the roots of plants. The company produces microbes and formulate them into a powder, which farmers rehydrate to awaken and apply at crop sowing. The microbes first proliferate alongside germinating plants, and then switch on nitrogen fertilizer production through a proprietary mechanism. This process is more efficient, lower cost, and has no toxic gas emissions or runoff. The company was founded by Elizabeth Sattely, Tim Schnabel, Jim Swartz, Jennifer Cochran, and Amy L. Chang, with Tim Schnabel as the CEO since incorporation. | Process Industries |
| Nodus Therapeutics, Inc. |
